Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization (Q33718170)

28 July 2017

title

Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization (English)

1 reference

28 July 2017

1 reference

David Taylor

1

0 references

author name string

Olubanke Olofinjana

series ordinal

2

1 reference

28 July 2017

publication date

1 July 2014

1 reference

International Clinical Psychopharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

29

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

229-234

1 reference

Risperidone and total 9-hydroxyrisperidone in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2002-2010.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047303

Health resource utilization associated with switching to risperidone long-acting injection

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24419004

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24419004

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24419004

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/YIC.0000000000000028

1 reference

28 July 2017

1 reference

28 July 2017

1 reference